BRPI0417037A - métodos de classificação de toxicidade retiniana - Google Patents

métodos de classificação de toxicidade retiniana

Info

Publication number
BRPI0417037A
BRPI0417037A BRPI0417037-7A BRPI0417037A BRPI0417037A BR PI0417037 A BRPI0417037 A BR PI0417037A BR PI0417037 A BRPI0417037 A BR PI0417037A BR PI0417037 A BRPI0417037 A BR PI0417037A
Authority
BR
Brazil
Prior art keywords
classification methods
toxicity classification
retinal toxicity
retinal
methods
Prior art date
Application number
BRPI0417037-7A
Other languages
English (en)
Inventor
Maria Eugenia Verdugo-Gazdik
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0417037A publication Critical patent/BRPI0417037A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"MéTODOS DE CLASSIFICAçãO DE TOXICIDADE RETINIANA". A presente invenção refere-se a métodos para caracterização de um agente de teste que utiliza um agente específico para integrina (<244>~ v~<225>~ 3~ e <244>~ v~<225>~ 5~ detectável por fluorescência, e uma célula epitelial de pigmento retiniano. A invenção refere-se ainda a kits tendo um agente específico para integrina <244>~ v~<225>~ 3~ e <244>~ v~<225> detectável por fluorescência, e uma célula epitelial de pigmento retiniano.
BRPI0417037-7A 2003-12-24 2004-12-13 métodos de classificação de toxicidade retiniana BRPI0417037A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53260803P 2003-12-24 2003-12-24
PCT/IB2004/004136 WO2005066629A1 (en) 2003-12-24 2004-12-13 Retinal toxicity screening methods

Publications (1)

Publication Number Publication Date
BRPI0417037A true BRPI0417037A (pt) 2007-02-06

Family

ID=34748813

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417037-7A BRPI0417037A (pt) 2003-12-24 2004-12-13 métodos de classificação de toxicidade retiniana

Country Status (6)

Country Link
US (1) US20050142068A1 (pt)
EP (1) EP1700118A1 (pt)
JP (1) JP2007517210A (pt)
BR (1) BRPI0417037A (pt)
CA (1) CA2550312A1 (pt)
WO (1) WO2005066629A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050248752A1 (en) * 2004-04-30 2005-11-10 Hall Gary W Solar rating system for intraocular lens implants
FR2888753B1 (fr) * 2005-07-21 2008-04-04 Commissariat Energie Atomique Vecteur cible avec fonction d'imagerie activable
FR2952300B1 (fr) * 2009-11-09 2012-05-11 Oreal Nouveaux colorants fluorescents a motif heterocyclique disulfure, composition de teinture les comprenant et procede de coloration des fibres keratiniques humaines a partir de ces colorants
EP2570139B1 (en) 2010-05-10 2019-08-07 Tsutomu Yasukawa Method for producing cell sheet
WO2014030749A1 (ja) 2012-08-24 2014-02-27 独立行政法人理化学研究所 網膜色素上皮細胞シートの製造方法
WO2020250854A1 (ja) * 2019-06-11 2020-12-17 富士フイルム株式会社 環状ペプチド、細胞足場材、細胞分離材、及び培地
WO2023210609A1 (ja) 2022-04-27 2023-11-02 ファーマバイオ株式会社 細胞シート作製方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266302A (en) * 1990-10-03 1993-11-30 Peyman Gholam A Method of performing angiography
IL137429A0 (en) * 1999-07-28 2001-07-24 Pfizer Prod Inc Methods and compsitions for treating diseases and conditions of the eye

Also Published As

Publication number Publication date
EP1700118A1 (en) 2006-09-13
CA2550312A1 (en) 2005-07-21
JP2007517210A (ja) 2007-06-28
WO2005066629A1 (en) 2005-07-21
US20050142068A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
BRPI0713375A2 (pt) dispositivo de ensaio descartável, e, método de ensaio
DK1049798T3 (da) Afprövning af antibiotikum-resistens
WO2006116127A3 (en) Compositions for use in identification of bacteria
WO2006094238A3 (en) Compositions for use in identification of adventitious viruses
BRPI0410418A (pt) fenil quinolinas e seu uso como moduladores do receptor de estrogênio
EP1893695B8 (en) Styryl sulfide dyes
BR0303080A (pt) Seleção de marcadores
ATE424560T1 (de) Marker für neuromyelitis optica
WO2008091814A3 (en) Assessment of asthma and allergen-dependent gene expression
DE602007000887D1 (de) Reagens, Ausstattung und Verfahren zur Probenanalyse
WO2005049849A3 (en) Fluorescence quenching azo dyes, their methods of preparation and use
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
AR059445A1 (es) Composiciones de antimicoticos ramnolipidicos y metodos de uso relacionados
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
GT200300046A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
BRPI0417037A (pt) métodos de classificação de toxicidade retiniana
BR0317229A (pt) Composição e uso de agonista completo de alfa7nachr
WO2007149809A3 (en) Tacrolimus standard and methods of using same
ATE534035T1 (de) Qualitätstests für antigenpräsentierende zellen
DE602005015559D1 (de) Pharmakodynamische tests mit durchflusszytometrie
WO2004016766A3 (en) Real time measurement of cellular responses
BR0215627A (pt) Suporte de componente e gerador de radioisótopos
BRPI0602671A (pt) processo para a preparação de terpolìmeros de nitrila de mooney baixa
BRPI0408056A (pt) uma composição de emulsão, um método para preparar uma composição de emulsão, uso de uma composição

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.